Corporate Profile

Corporate Profile


Integrating resources for greater operating synergy

Company Name LSI Medience Corporation
Head office map13-4, Uchikanda 1-chome, Chiyoda-ku Tokyo
President and CEO Haruo Watanabe
Paid-in capital 3 billion yen
Sales Revenue 89.5 billion yen(as of March,2020)
Primary Business Domains ・Clinical testing (biochemical testing, hematological testing, immunological testing, microbiological testing, genetic testing, pathological and other testing)
・Development, sale, export and import of in vitro diagnostic reagents and instruments
・Preventive medical services
・Medical services
・Drug development support services (Clinical study)
・In vitro cell assay (human cell)
・Gene and protein analysis services
・Environmental risk Assesment (pharmaceuticals, agrochemicals, industrial chemicals, food additives and cosmetics)
・Food Safety Support services
・Anti-Doping test (sample analysis by WADA code)
Number of employees
(whole group)
3,600(as of March,2020)
As of Apr.1.2021
Executives and Operating Executives Representative Director,Member of the Board
President and Chief Executive Officer
Haruo Watanabe
Representative Director,Member of the Board
Managing Director
Satoru Kusunoki
Member of the Board
Managing Director
Toshihiko Niwa
Member of the Board
Managing Director
Kenichi Uchino
Member of the Board Koichiro Ota
Member of the Board Noboru Horiuchi
Member of the Board Shoji Miyazaki
Executive Officer Takashi Kurihara
Executive Officer Mitsuru Suzuki
Executive Officer Takeshi Masuda
Executive Officer Nobuteru Matsuo
Executive Officer Akira Myojo
Executive Officer Junko Murase
Executive Officer Masaru Yamada
Audit & Supervisory Board Member Toshiyuki Itou
Audit & Supervisory Board Member Nobuhisa Uchida
Audit & Supervisory Board Member Norio Ubukata



Diagnostics Testing | Nonclinical & Clinical Services | Food Sanitation & Hygiene Analysis | Doping Tests | Corporate Profile | Quality & Environmental Policy | Recruiting Info